Product Program year 2025 Source: CMS Open Payments

Evera MRI XT Dr Surescan

Device Implantable Cardioverter Defibrillators (ICDs)

PDI 00643169720497

Open in the dashboard

General payments

$1,028,905

7,303 payments

Research payments

$0

0 payments

Through program year 2025, $1,028,905 in general payments and $0 in research payments were reported against Evera MRI XT Dr Surescan (Implantable Cardioverter Defibrillators (ICDs)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $470,854 3,083
2024 General $530,161 3,712
2023 General $22,341 330
2022 General $5,549 178

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $1,028,905 7,303 payments
Top recipients General payments · program year 2025
  1. Oliver Monfredi Clinical Cardiac Electrophysiology · Charlottesville, VA $9,872 2% · 58 payments
  2. Timothy Markman Clinical Cardiac Electrophysiology · Philadelphia, PA $5,616 1% · 34 payments
  3. Edmond Cronin Clinical Cardiac Electrophysiology · Philadelphia, PA $5,109 1% · 37 payments
  4. Jens Philip Aagaard Clinical Cardiac Electrophysiology · Park Ridge, IL $5,073 1% · 39 payments
  5. Natalie Bradford Clinical Cardiac Electrophysiology · Winston Salem, NC $3,994 <1% · 28 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $351,094 76% · 360 practitioners
  2. Cardiovascular Disease Internal Medicine $48,223 10% · 81 practitioners
  3. Pediatric Cardiology Pediatrics $17,457 4% · 19 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $13,596 3% · 15 practitioners
  5. Internal Medicine $10,029 2% · 31 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $51,645 11% · 53 recipients
  2. California $37,468 8% · 48 recipients
  3. New York $35,853 8% · 46 recipients
  4. Florida $30,788 7% · 60 recipients
  5. Pennsylvania $27,450 6% · 20 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

7,303 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record